HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy

Phase 2

Terminated

Conditions: Duchenne Muscular Dystrophy
Becker Muscular Dystrophy

Interventions: Drug: Sildenafil

First Posted Date: 2010-07-23

Last Posted Date: 2019-02-26

Lead Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Target Recruit Count: 20

Registration Number: NCT01168908

Locations: 🇺🇸
Kennedy Krieger Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, United States

Yulex Glove Prospective Study in Spina Bifida

Not Applicable

Terminated

Conditions: Spina Bifida
Latex Allergy

First Posted Date: 2010-05-28

Last Posted Date: 2011-12-23

Lead Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Target Recruit Count: 7

Registration Number: NCT01133288

Locations: 🇺🇸
Hugo W. Moser Research Institute at Kennedy Krieger Inc., Baltimore, Maryland, United States

A Randomized Clinical Trial for Toddlers With ASD

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Social communication

First Posted Date: 2009-11-06

Last Posted Date: 2021-03-10

Lead Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Target Recruit Count: 196

Registration Number: NCT01008800

Locations: 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

Patterned Functional Electrical Stimulation (FES) Ergometry of Arm and Shoulder in Individuals With Spinal Cord Injury

Phase 1

Terminated

Conditions: Spinal Cord Injury

Interventions: Device: Non-FES Upper Extremity Exercise
Device: RT300-SLSA, from Restorative Therapies, Inc.

First Posted Date: 2009-11-01

Last Posted Date: 2023-01-05

Lead Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Target Recruit Count: 19

Registration Number: NCT01005615

Locations: 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

Trial of Dextromethorphan in Rett Syndrome

Phase 2

Terminated

Conditions: Rett Syndrome

Interventions: Drug: Dextromethorphan

First Posted Date: 2008-01-15

Last Posted Date: 2014-04-23

Lead Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Target Recruit Count: 38

Registration Number: NCT00593957

Locations: 🇺🇸
Kennedy Krieger Institute/Johns Hopkins Medical Institutions, Baltimore, Maryland, United States

School- and Home-Based Early Intervention for Toddlers With Autism

Not Applicable

Completed

Conditions: Autistic Disorder
Autism

Interventions: Behavioral: Early intervention blending several tx approaches, w/ focus
Behavioral: Early intervention blending several treatment approaches

First Posted Date: 2005-03-22

Last Posted Date: 2013-07-08

Lead Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Target Recruit Count: 50

Registration Number: NCT00106210

Locations: 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy

Phase 2

Terminated

Conditions: Adrenoleukodystrophy

Interventions: Drug: glyceryl trierucate/glyceryl trioleate

First Posted Date: 1999-10-19

Last Posted Date: 2020-10-23

Lead Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Target Recruit Count: 126

Registration Number: NCT00004418

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy